| scholarly article | Q13442814 |
| P50 | author | Nico van Rooijen | Q62569422 |
| Gwendalyn J. Randolph | Q88180808 | ||
| P2093 | author name string | Sergio A Lira | |
| Frank Tacke | |||
| Matthias Mack | |||
| Jianhua Liu | |||
| Rainer Spanbroek | |||
| David Alvarez | |||
| Alexandre Garin | |||
| Claudia Jakubzick | |||
| Andreas J Habenicht | |||
| Jaime Llodra | |||
| Theodore J Kaplan | |||
| P2860 | cites work | Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor | Q36380911 |
| Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes | Q36399533 | ||
| Dynamic imaging of the immune system: progress, pitfalls and promise | Q36518928 | ||
| Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques | Q37416056 | ||
| The fractalkine receptor CX3CR1 is a key mediator of atherogenesis | Q39745003 | ||
| The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. | Q40271786 | ||
| Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications | Q40701479 | ||
| Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease | Q43777934 | ||
| The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. | Q45025551 | ||
| Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. | Q46754468 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. | Q47914837 | ||
| Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. | Q52549466 | ||
| Mouse model of heterotopic aortic arch transplantation | Q56971847 | ||
| Role of Bone Marrow–Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice | Q58149249 | ||
| Deficiency in CCR5 but not CCR1 protects against neointima formation in atherosclerosis-prone mice: involvement of IL-10 | Q61612313 | ||
| Quantitative immunocytochemical characterization of mononuclear phagocytes. II. Monocytes and tissue macrophages | Q68204087 | ||
| Differential chemokine receptor expression and function in human monocyte subpopulations | Q73792772 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease | Q78594580 | ||
| Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1) | Q79214234 | ||
| Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice | Q95721029 | ||
| Langerhans cells arise from monocytes in vivo | Q28294423 | ||
| Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 | ||
| Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. | Q28590391 | ||
| Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
| In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens | Q29615098 | ||
| Visualizing dendritic cell networks in vivo | Q29616233 | ||
| Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion | Q29618089 | ||
| CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance | Q29620412 | ||
| Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 | Q29622852 | ||
| The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium | Q30308237 | ||
| L-selectin: mechanisms and physiological significance of ectodomain cleavage. | Q30437162 | ||
| CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice | Q30891436 | ||
| Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair | Q33565774 | ||
| Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root | Q33580505 | ||
| Generation and analysis of mice lacking the chemokine fractalkine | Q33941435 | ||
| The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells | Q34512207 | ||
| Chemokine receptor CCR1 disruption in bone marrow cells enhances atherosclerotic lesion development and inflammation in mice | Q34572318 | ||
| Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease | Q34772143 | ||
| Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis | Q34828549 | ||
| Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans | Q34912596 | ||
| Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies | Q35173613 | ||
| The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics | Q35689477 | ||
| Chemokines in the pathogenesis of vascular disease | Q35932790 | ||
| Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery | Q36228368 | ||
| The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies | Q36351071 | ||
| Fractalkine preferentially mediates arrest and migration of CD16+ monocytes | Q36370923 | ||
| Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues | Q36376423 | ||
| The CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting | Q36376577 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 185-194 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques | |
| P478 | volume | 117 |
| Q36941513 | 1,25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients |
| Q36710876 | 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis |
| Q38888701 | 2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development. |
| Q30252768 | A MicroRNA93-Interferon Regulatory Factor-9-Immunoresponsive Gene-1-Itaconic Acid Pathway Modulates M2-Like Macrophage Polarization to Revascularize Ischemic Muscle |
| Q52684469 | A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. |
| Q55064059 | A Polecat's View of Patrolling Monocytes. |
| Q34776498 | A mouse model of yellow fluorescent protein (YFP) expression in hematopoietic cells to assess leukocyte-endothelial interactions in the microcirculation |
| Q42485407 | A novel flow cytometry-based assay to study leukocyte-endothelial cell interactions in vitro |
| Q36771337 | A novel murine model of rhinoscleroma identifies Mikulicz cells, the disease signature, as IL-10 dependent derivatives of inflammatory monocytes. |
| Q42707351 | A novel type I IFN-producing cell subset in murine lupus |
| Q35901388 | AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-κB Pathway in RAW264.7 Macrophages |
| Q37153606 | ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression |
| Q41789790 | ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation |
| Q89876337 | Aberrant activation of bone marrow Ly6C high monocytes in diabetic mice contributes to impaired glucose tolerance |
| Q35565755 | Aberrant regulation of the integrin very late antigen-4 in systemic lupus erythematosus |
| Q42707203 | Absence of CCR2 results in an inflammaging environment in young mice with age-independent impairments in muscle regeneration |
| Q37635019 | Activated niacin receptor HCA2 inhibits chemoattractant-mediated macrophage migration via Gβγ/PKC/ERK1/2 pathway and heterologous receptor desensitization |
| Q41905308 | Activation-induced degradation of FLIP(L) is mediated via the phosphatidylinositol 3-kinase/Akt signaling pathway in macrophages |
| Q36661058 | Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. |
| Q42848637 | Adipose Tissue Dendritic Cells Are Independent Contributors to Obesity-Induced Inflammation and Insulin Resistance. |
| Q33862296 | Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes |
| Q33724394 | Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity |
| Q44203361 | Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells. |
| Q37066948 | Age-associated vascular inflammation promotes monocytosis during atherogenesis. |
| Q33611462 | Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults |
| Q34791186 | Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration |
| Q53657848 | Aged mice have increased inflammatory monocyte concentration and altered expression of cell-surface functional receptors. |
| Q50568735 | Ager Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice. |
| Q92494933 | Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis |
| Q97074426 | Alterations of CCR2 and CX3CR1 on Three Monocyte Subsets During HIV-1/Treponema pallidum Coinfection |
| Q50695778 | Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. |
| Q24300694 | An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion |
| Q91689575 | Analysis of interleukin-17 and interleukin-18 levels in animal models of atherosclerosis |
| Q37093590 | Angiogenesis in eye disease: immunity gained or immunity lost? |
| Q43143507 | Angiogenic monocytes: another colorful blow to endothelial progenitors |
| Q37572203 | Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes |
| Q35903298 | Animal models of atherosclerosis |
| Q27012536 | Anti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cells |
| Q39635867 | Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin |
| Q37045337 | Antigen presentation by monocytes and monocyte-derived cells |
| Q37439900 | Antiretroviral treatment interruptions and risk of non-opportunistic diseases |
| Q35370268 | ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice |
| Q35744441 | ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endothelium |
| Q90367399 | Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation |
| Q42175264 | Apoptotic cell-derived ICAM-3 promotes both macrophage chemoattraction to and tethering of apoptotic cells. |
| Q58574858 | Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases |
| Q33624371 | Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study. |
| Q30424809 | Arteriolar and venular remodeling are differentially regulated by bone marrow-derived cell-specific CX3CR1 and CCR2 expression |
| Q40784219 | Association of hydrogen sulfide with alterations of monocyte chemokine receptors, CCR2 and CX3CR1 in patients with coronary artery disease |
| Q42238390 | Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals. |
| Q57132044 | Atherosclerosis |
| Q38217731 | Atherosclerosis--multiple pathways to lesional macrophages |
| Q37953777 | Atherosclerosis: current pathogenesis and therapeutic options |
| Q51105552 | Atractylenolide I restores HO-1 expression and inhibits Ox-LDL-induced VSMCs proliferation, migration and inflammatory responses in vitro. |
| Q35728941 | Balance of inflammatory pathways and interplay of immune cells in the liver during homeostasis and injury |
| Q36079808 | Beyond vascular inflammation--recent advances in understanding atherosclerosis |
| Q27693877 | Biomechanical factors and macrophages in plaque stability |
| Q55640686 | Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis. |
| Q41147790 | Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice |
| Q41484602 | Bone morphogenetic protein 9 (BMP9) and BMP10 enhance tumor necrosis factor-α-induced monocyte recruitment to the vascular endothelium mainly via activin receptor-like kinase 2. |
| Q45962394 | CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis. |
| Q30803044 | CCN1/CYR61-mediated meticulous patrolling by Ly6Clow monocytes fuels vascular inflammation |
| Q33533950 | CCR2 and coronary artery disease: a woscops substudy |
| Q37249670 | CCR2 promotes hepatic fibrosis in mice |
| Q33816303 | CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells |
| Q41576199 | CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis |
| Q33696840 | CD11c expression in adipose tissue and blood and its role in diet-induced obesity |
| Q42629748 | CD11c/CD18 Signals Very Late Antigen-4 Activation To Initiate Foamy Monocyte Recruitment during the Onset of Hypercholesterolemia |
| Q35684739 | CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so |
| Q92717753 | CD146 deficiency promotes plaque formation in a mouse model of atherosclerosis by enhancing RANTES secretion and leukocyte recruitment |
| Q36629448 | CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer |
| Q36922514 | CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes |
| Q34163933 | CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice |
| Q33554073 | CX3CR1 deficiency does not influence trafficking of adipose tissue macrophages in mice with diet-induced obesity |
| Q36392588 | CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production |
| Q35692948 | CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis |
| Q34627881 | CX3CR1 signaling on monocytes is dispensable after intracerebral hemorrhage |
| Q43290133 | CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis |
| Q34096557 | CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses |
| Q37346711 | CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses. |
| Q34501912 | CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway. |
| Q37183722 | CYP450-derived oxylipins mediate inflammatory resolution. |
| Q37217500 | Calpain-6 confers atherogenicity to macrophages by dysregulating pre-mRNA splicing |
| Q36160819 | Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction |
| Q35952700 | Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. |
| Q35566342 | Cellular and 3D optical coherence tomography assessment during the initiation and progression of retinal degeneration in the Ccl2/Cx3cr1-deficient mouse |
| Q38811208 | Cellular recruitment in myocardial ischaemia/reperfusion injury. |
| Q36765892 | Characterization of Distinct Macrophage Subpopulations during Nitrogen Mustard-Induced Lung Injury and Fibrosis. |
| Q42688383 | Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice |
| Q64262203 | Chemokine Receptor Redundancy and Specificity Are Context Dependent |
| Q26863520 | Chemokine contribution in stem cell engraftment into the infarcted myocardium |
| Q34672038 | Chemokine receptor CCR5: from AIDS to atherosclerosis |
| Q34248596 | Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis |
| Q37481304 | Chemokine receptor antagonists: part 2. |
| Q58758969 | Chemokine-Induced Macrophage Polarization in Inflammatory Conditions |
| Q37345875 | Chemokine-directed immune cell infiltration in acute and chronic liver disease |
| Q26801787 | Chemokines and their receptors in Atherosclerosis |
| Q27024341 | Chemokines as effector and target molecules in vascular biology |
| Q37849900 | Chemokines as targets for therapy |
| Q37652971 | Chemokines in the vascular inflammatory response of atherosclerosis |
| Q37950973 | Chemokines: established and novel targets in atherosclerosis |
| Q36016640 | Chimeric antigen receptor T cells shape myeloid cell function within the tumor microenvironment through IFN-γ and GM-CSF. |
| Q26861206 | Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis |
| Q54648069 | Cholesterol, CCR2, and monocyte phenotypes in atherosclerosis. |
| Q34903713 | Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways |
| Q30389726 | Circadian Influence on Metabolism and Inflammation in Atherosclerosis |
| Q90984773 | Circulating CD14+CD16- classical monocytes do not associate with a vulnerable plaque phenotype, and do not predict secondary events in severe atherosclerotic patients |
| Q37151168 | Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. |
| Q38411099 | Clinical significance of monocyte heterogeneity |
| Q33608738 | Comparison of gene expression profiles between human and mouse monocyte subsets |
| Q92983083 | Constitutive and stimulated macropinocytosis in macrophages: roles in immunity and in the pathogenesis of atherosclerosis |
| Q30318502 | Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis |
| Q36879234 | Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice. |
| Q38025388 | Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis. |
| Q37150841 | Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype |
| Q35640438 | Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. |
| Q52691045 | DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice. |
| Q91120596 | DNA methyltransferase 1 and Krüppel-like factor 4 axis regulates macrophage inflammation and atherosclerosis |
| Q64958310 | Data on leukocyte PDZK1 deficiency affecting macrophage apoptosis but not monocyte recruitment, cell proliferation, macrophage abundance or ER stress in atherosclerotic plaques of LDLR deficient mice. |
| Q97525815 | Deciphering Macrophage Phenotypes upon Lipid Uptake and Atherosclerosis |
| Q47132046 | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
| Q89113492 | Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis |
| Q37033745 | Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice |
| Q35159004 | Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication |
| Q33656103 | Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile |
| Q38740877 | Dendritic Cell Trafficking and Function in Rare Lung Diseases |
| Q38310937 | Dendritic Cells and Macrophages: Sentinels in the Kidney |
| Q37624571 | Dendritic cells in atherosclerosis |
| Q33651897 | Dendritic cells in atherosclerotic disease |
| Q36490200 | Depletion of CD11c⁺ cells in the CD11c.DTR model drives expansion of unique CD64⁺ Ly6C⁺ monocytes that are poised to release TNF-α |
| Q38691116 | Development and Function of Arterial and Cardiac Macrophages |
| Q39271567 | Development and Functional Differentiation of Tissue-Resident Versus Monocyte-Derived Macrophages in Inflammatory Reactions |
| Q50125858 | Development of an inflammation imaging tracer, 111In-DOTA-DAPTA, targeting chemokine receptor CCR5 and preliminary evaluation in an ApoE-/- atherosclerosis mouse model. |
| Q50021708 | Diabetes-mediated myelopoiesis and the relationship to cardiovascular risk. |
| Q57468635 | Different phenotypes of non-classical monocytes associated with systemic inflammation, endothelial alteration and hepatic compromise in patients with dengue |
| Q52560150 | Differential Interaction of Platelet-Derived Extracellular Vesicles with Leukocyte Subsets in Human Whole Blood. |
| Q36414956 | Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis |
| Q43083885 | Differential expression of the fractalkine chemokine receptor (CX3CR1) in human monocytes during differentiation |
| Q28742298 | Discrete derivative: a data slicing algorithm for exploration of sharing biological networks between rheumatoid arthritis and coronary heart disease |
| Q36773876 | Disordered haematopoiesis and athero-thrombosis. |
| Q36776429 | Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice |
| Q41106375 | Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes |
| Q27333694 | Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques |
| Q21285000 | Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery |
| Q55236746 | Dual Affinity Heparin-Based Hydrogels Achieve Pro-Regenerative Immunomodulation and Microvascular Remodeling. |
| Q37723178 | Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases |
| Q42134468 | Dynamic immune cell accumulation during flow-induced atherogenesis in mouse carotid artery: an expanded flow cytometry method |
| Q41781398 | Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein. |
| Q38903993 | Effects of dyslipidaemia on monocyte production and function in cardiovascular disease |
| Q49891102 | Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia. |
| Q35132366 | Effects of niacin on atherosclerosis and vascular function |
| Q39800370 | Efferocytosis as a regulator of macrophage chemokine receptor expression and polarization. |
| Q35391967 | Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia |
| Q90050698 | Emerging Roles for G-protein Coupled Receptors in Development and Activation of Macrophages |
| Q26739691 | Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? |
| Q37260168 | Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis |
| Q89266988 | Endogenous Protection from Ischemic Brain Injury by Preconditioned Monocytes |
| Q30853668 | Endothelial Protective Monocyte Patrolling in Large Arteries Intensified by Western Diet and Atherosclerosis |
| Q28744262 | Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis |
| Q37846143 | Epithelial-mesenchymal interactions in biliary diseases |
| Q38507723 | Equivalence testing in microarray analysis: similarities in the transcriptome of human atherosclerotic and nonatherosclerotic macrophages. |
| Q36862946 | Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages |
| Q37200899 | Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression |
| Q37078664 | Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice |
| Q35985220 | Expanding role of delta-like 4 mediated notch signaling in cardiovascular and metabolic diseases |
| Q51772184 | Expression of C-type lectin, SIGNR3, on subsets of dendritic cells, macrophages, and monocytes |
| Q35687871 | Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions |
| Q37082023 | Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes |
| Q57169759 | Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease |
| Q38860053 | Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia |
| Q36366267 | Folate receptor: a macrophage "achilles' heel"? |
| Q36660105 | Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis |
| Q34391705 | Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1. |
| Q38179249 | From proliferation to proliferation: monocyte lineage comes full circle |
| Q35889058 | Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis |
| Q33604746 | Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis |
| Q47598616 | Functional diversity of macrophages in vascular biology and disease. |
| Q38217345 | Functional genomics of the 9p21.3 locus for atherosclerosis: clarity or confusion? |
| Q37276351 | Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia |
| Q39499494 | Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo |
| Q36331567 | Functional role of monocytes and macrophages for the inflammatory response in acute liver injury |
| Q38715488 | G protein-coupled receptors as targets for anti-diabetic therapeutics |
| Q64935464 | G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis. |
| Q42577780 | GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions |
| Q28287747 | GPR109A and vascular inflammation |
| Q37163430 | Gastrointestinal inflammation: lessons from metabolic modulators |
| Q27316270 | Genetic and pharmacological modifications of thrombin formation in apolipoprotein e-deficient mice determine atherosclerosis severity and atherothrombosis onset in a neutrophil-dependent manner |
| Q37165196 | Genetic polymorphisms in the CD14 gene are associated with monocyte activation and carotid intima-media thickness in HIV-infected patients on antiretroviral therapy |
| Q91559781 | Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice |
| Q38258044 | Glycosyltransferases, glycosylation and atherosclerosis |
| Q27330751 | Graft-infiltrating host dendritic cells play a key role in organ transplant rejection |
| Q42288906 | Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis |
| Q46224865 | HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy |
| Q33868782 | HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells |
| Q35949916 | Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility |
| Q39939397 | Hematopoietic stem/progenitor cells directly contribute to arteriosclerotic progression via integrin β2 |
| Q58726638 | Hemodialysis-related changes in phenotypical features of monocytes |
| Q49524850 | Hepatic recruitment of CD11b+Ly6C+ inflammatory monocytes promotes hepatic ischemia/reperfusion injury. |
| Q62735118 | Hepatic recruitment of the inflammatory Gr1+monocyte subset upon liver injury promotes hepatic fibrosis |
| Q36512340 | Heterogeneity of human macrophages in culture and in atherosclerotic plaques |
| Q83393584 | Heterogeneity of human monocytes: an optimized four-color flow cytometry protocol for analysis of monocyte subsets |
| Q30409523 | Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors |
| Q37446568 | Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis |
| Q36546975 | High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1. |
| Q34555169 | Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer |
| Q91638984 | How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy |
| Q58562247 | How toll-like receptors reveal monocyte plasticity: the cutting edge of antiinflammatory therapy |
| Q34318508 | Human CD68 promoter GFP transgenic mice allow analysis of monocyte to macrophage differentiation in vivo. |
| Q90724364 | Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry |
| Q36920492 | Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. |
| Q27332432 | Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression |
| Q36951483 | Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: studies in mice and FH children |
| Q38066291 | Hypercholesterolemia links hematopoiesis with atherosclerosis. |
| Q37711215 | Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis |
| Q36140871 | IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB. |
| Q37234314 | Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves |
| Q24649151 | Identification of splenic reservoir monocytes and their deployment to inflammatory sites |
| Q38064660 | Imaging macrophage development and fate in atherosclerosis and myocardial infarction |
| Q44183906 | Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRI. |
| Q39636702 | Imaging of hypoxia in mouse atherosclerotic plaques with (64)Cu-ATSM. |
| Q30316648 | Imaging systemic inflammatory networks in ischemic heart disease |
| Q37325024 | Immune and inflammatory mechanisms of atherosclerosis (*) |
| Q64979483 | Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity. |
| Q37150605 | Immune effector mechanisms implicated in atherosclerosis: from mice to humans |
| Q57132246 | Immunological aspects of atherosclerosis: Figure 1 |
| Q24595843 | Immunology. Dispensable but not irrelevant |
| Q36152926 | Impact of bariatric surgery on carotid artery inflammation and the metabolic activity in different adipose tissues. |
| Q84521080 | Impact of chemokine receptor CX3CR1 in human renal allograft rejection |
| Q31132267 | Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis |
| Q39982049 | Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. |
| Q51345939 | In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice. |
| Q30543940 | In vivo imaging implicates CCR2(+) monocytes as regulators of neutrophil recruitment during arthritis |
| Q42379000 | In vivo imaging of lung inflammation with neutrophil-specific 68Ga nano-radiotracer |
| Q27315813 | Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells |
| Q57160461 | Increased ROS production and DNA damage in monocytes are biomarkers of aging and atherosclerosis |
| Q37310434 | Increased atherosclerotic lesions in LDL receptor deficient mice with hematopoietic nuclear receptor Rev-erbα knock- down |
| Q35696560 | Increased macrophage migration into adipose tissue in obese mice |
| Q37351980 | Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. |
| Q59329436 | Infection-Induced Transcriptional Changes in Hepatic Macrophage Metabolism Correlate With an Athero-Protective Phenotype |
| Q37255877 | Inflamed adipose tissue, insulin resistance and vascular injury |
| Q38077322 | Inflammation and atherosclerosis: direct versus indirect mechanisms |
| Q38083555 | Inflammation and immune system interactions in atherosclerosis |
| Q33834800 | Inflammation and its resolution as determinants of acute coronary syndromes |
| Q36174933 | Inflammation in atherosclerosis |
| Q33709505 | Inflammation in atherosclerosis: from pathophysiology to practice |
| Q36177467 | Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients |
| Q42644126 | Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression |
| Q52720539 | Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes. |
| Q28275259 | Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications |
| Q35688241 | Inflammatory monocyte effector mechanisms |
| Q26861256 | Inflammatory monocytes and the pathogenesis of viral encephalitis |
| Q47289858 | Inflammatory monocytes mediate control of acute alphavirus infection in mice. |
| Q29622851 | Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis |
| Q37207091 | Inflammatory pathways in liver homeostasis and liver injury |
| Q38788685 | Inflammatory processes in cardiovascular disease: a route to targeted therapies |
| Q89838814 | Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe-/- Mice |
| Q102142948 | Inhibition of interleukin-1β signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis |
| Q24634492 | Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development |
| Q33659705 | Innate and adaptive immunity in atherosclerosis |
| Q56961974 | Innate and adaptive immunity in atherosclerosis |
| Q34980214 | Innate immunity and monocyte-macrophage activation in atherosclerosis. |
| Q55253701 | Insights From Pre-Clinical and Clinical Studies on the Role of Innate Inflammation in Atherosclerosis Regression. |
| Q36984213 | Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice |
| Q51302492 | Integrin αMβ2 is differently expressed by subsets of human osteoclast precursors and mediates adhesion of classical monocytes to bone. |
| Q39150057 | Interaction of endothelial cells with macrophages-linking molecular and metabolic signaling |
| Q41874262 | Interleukin 17 receptor A modulates monocyte subsets and macrophage generation in vivo |
| Q36379539 | Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype |
| Q30421700 | Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms |
| Q33881232 | Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency |
| Q48575325 | Intermediate and nonclassical monocytes show heterogeneity in patients with different types of acute coronary syndrome. |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q26852026 | Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction |
| Q37522003 | Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. |
| Q36204857 | Intimal pericytes as the second line of immune defence in atherosclerosis |
| Q92049193 | KLF2 in Myeloid Lineage Cells Regulates the Innate Immune Response during Skeletal Muscle Injury and Regeneration |
| Q38031130 | Kruppel-like factors and vascular inflammation: implications for atherosclerosis |
| Q40645397 | LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis |
| Q34360087 | LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression |
| Q64112194 | Lack of IκBNS promotes cholate-containing high-fat diet-induced inflammation and atherogenesis in low-density lipoprotein (LDL) receptor-deficient mice |
| Q33561481 | Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models |
| Q34322056 | Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure |
| Q36654171 | Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". |
| Q34668164 | Lifestyle effects on hematopoiesis and atherosclerosis |
| Q89107293 | Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report |
| Q53698113 | Linkage of Infection to Adverse Systemic Complications: Periodontal Disease, Toll-Like Receptors, and Other Pattern Recognition Systems. |
| Q37556042 | Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio. |
| Q35140825 | Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes |
| Q37156803 | Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion |
| Q28071784 | Live cell imaging to understand monocyte, macrophage, and dendritic cell function in atherosclerosis |
| Q43219972 | Liver fibrosis - pathogenesis and novel therapeutic approaches |
| Q34492178 | Local effects of human PCSK9 on the atherosclerotic lesion |
| Q47405015 | Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction |
| Q37161176 | Local proliferation dominates lesional macrophage accumulation in atherosclerosis |
| Q26750473 | Long-term activation of the innate immune system in atherosclerosis |
| Q42987834 | Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis |
| Q36537611 | Longitudinal, Diet-induced Weight Gain is Associated with Increased Blood Monocytes and Reduced TLR4 Expression |
| Q39938314 | Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages |
| Q24628806 | Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent |
| Q90131716 | Lung Transplantation Has a Strong Impact on the Distribution and Phenotype of Monocyte Subsets |
| Q43511144 | Ly-6C(hi) monocytes: a potential target for preventing transplant arteriosclerosis? |
| Q35644935 | Ly6C- Monocytes Regulate Parasite-Induced Liver Inflammation by Inducing the Differentiation of Pathogenic Ly6C+ Monocytes into Macrophages |
| Q27486985 | Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis |
| Q36979954 | Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes |
| Q38776911 | Lymphatic network in atherosclerosis: the underestimated path. |
| Q33399367 | Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice |
| Q54541923 | M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. |
| Q64120737 | M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment |
| Q40414424 | MARCH1 E3 Ubiquitin Ligase Dampens the Innate Inflammatory Response by Modulating Monocyte Functions in Mice. |
| Q26800135 | MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities |
| Q57185167 | MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis |
| Q51736533 | MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis. |
| Q36602809 | Macrophage Phenotype and Function in Different Stages of Atherosclerosis |
| Q58592678 | Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2) |
| Q36584242 | Macrophage autophagy in atherosclerosis |
| Q36196806 | Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice |
| Q38008842 | Macrophage differentiation and function in atherosclerosis: opportunities for therapeutic intervention? |
| Q36955562 | Macrophage diversity in renal injury and repair. |
| Q38893448 | Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases |
| Q42023507 | Macrophage heterogeneity and tissue lipids |
| Q37594434 | Macrophage heterogeneity in atherosclerotic plaques |
| Q26861223 | Macrophage heterogeneity in tissues: phenotypic diversity and functions |
| Q39867198 | Macrophage inflammatory protein-1beta induced cell adhesion with increased intracellular reactive oxygen species |
| Q42223802 | Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. |
| Q37624935 | Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages. |
| Q38554081 | Macrophage polarization in pathology |
| Q37990243 | Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine |
| Q89463384 | Macrophage subsets in atherosclerosis as defined by single-cell technologies |
| Q40558304 | Macrophage/monocyte-specific deletion of Ras homolog gene family member A (RhoA) downregulates fractalkine receptor and inhibits chronic rejection of mouse cardiac allografts. |
| Q63915886 | Macrophages and Cardiovascular Health |
| Q39271676 | Macrophages and RhoA Pathway in Transplanted Organs. |
| Q38462573 | Macrophages and immune cells in atherosclerosis: recent advances and novel concepts |
| Q49026058 | Macrophages and lipid metabolism. |
| Q37294955 | Macrophages heterogeneity in atherosclerosis - implications for therapy. |
| Q34368005 | Macrophages in atherosclerosis: a dynamic balance. |
| Q30525251 | Macrophages in collateral arteriogenesis. |
| Q38965333 | Macrophages in neuroinflammation: role of the renin-angiotensin-system. |
| Q29617765 | Macrophages in the pathogenesis of atherosclerosis |
| Q39123553 | Macrophages in vascular inflammation and atherosclerosis |
| Q26825052 | Macrophages in vascular inflammation--From atherosclerosis to vasculitis |
| Q30432565 | Macrophages, dendritic cells, and kidney ischemia-reperfusion injury |
| Q64106073 | Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation |
| Q36218472 | Making a difference: monocyte heterogeneity in cardiovascular disease |
| Q37154824 | Matrine Inhibits Infiltration of the Inflammatory Gr1(hi) Monocyte Subset in Injured Mouse Liver through Inhibition of Monocyte Chemoattractant Protein-1 |
| Q37272221 | Mechanisms and consequences of dendritic cell migration |
| Q37097322 | Mechanisms of failed apoptotic cell clearance by phagocyte subsets in cardiovascular disease |
| Q39294420 | Mechanisms of hepatic stellate cell activation |
| Q37096570 | Mechanisms of leukocyte migration across the blood-retina barrier |
| Q33761114 | Mechanisms that regulate macrophage burden in atherosclerosis |
| Q49190975 | Melanocortin 1 Receptor Deficiency Promotes Atherosclerosis in Apolipoprotein E-/- Mice. |
| Q85945994 | Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25 (+)FOXP3 (+) regulatory T-cells and inhibiting macrophage foam cell formation |
| Q60961590 | Metabolism Plays a Key Role during Macrophage Activation |
| Q38771095 | Metalloproteinase production from macrophages - a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction |
| Q63560419 | Methods to Study Monocyte and Macrophage Trafficking in Atherosclerosis Progression and Resolution |
| Q55514960 | MicroRNA 33 Regulates the Population of Peripheral Inflammatory Ly6Chigh Monocytes through Dual Pathways. |
| Q36519806 | MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-/- mice |
| Q57170593 | MicroRNAs and immunity in periodontal health and disease |
| Q37623996 | Microdomains, Inflammation, and Atherosclerosis. |
| Q35269888 | Microparticles from apoptotic platelets promote resident macrophage differentiation. |
| Q28083768 | Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes |
| Q41824538 | Mobilization and margination of bone marrow Gr-1high monocytes during subclinical endotoxemia predisposes the lungs toward acute injury |
| Q47196473 | Modulation of Gr1low monocyte subset impacts insulin sensitivity and weight gain upon high-fat diet in female mice. |
| Q35591762 | Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice |
| Q64913160 | Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis. |
| Q87439859 | Molecular mechanisms regulating CD13-mediated adhesion |
| Q37992524 | Molecular pathways regulating macrophage polarization: implications for atherosclerosis |
| Q40959246 | Monocyte Adhesion and Plaque Recruitment During Atherosclerosis Development Is Regulated by the Adapter Protein Chat-H/SHEP1 |
| Q92188890 | Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors |
| Q47598516 | Monocyte Recruitment Versus Macrophage Proliferation in Atherosclerosis |
| Q47854446 | Monocyte Subsets Are Differentially Lost from the Circulation during Acute Inflammation Induced by Human Experimental Endotoxemia. |
| Q37890185 | Monocyte and macrophage dynamics during atherogenesis |
| Q37122225 | Monocyte and macrophage heterogeneity in the heart |
| Q26991973 | Monocyte heterogeneity in cardiovascular disease |
| Q43143047 | Monocyte mayhem: do subtypes modulate distinct atherosclerosis phenotypes? |
| Q29620067 | Monocyte recruitment during infection and inflammation |
| Q37992796 | Monocyte subpopulations and cardiovascular risk in chronic kidney disease |
| Q33450605 | Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors |
| Q50065330 | Monocyte subsets and their phenotypes during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia. |
| Q35230750 | Monocyte trafficking in acute and chronic inflammation |
| Q34065838 | Monocyte trafficking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression |
| Q47632654 | Monocyte-Macrophages and T Cells in Atherosclerosis |
| Q37116502 | Monocyte-endothelial cell interactions in the development of atherosclerosis |
| Q38791792 | Monocyte-mediated defense against bacteria, fungi, and parasites |
| Q34065898 | Monocyte-mediated defense against microbial pathogens. |
| Q38079293 | Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q33949943 | Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. |
| Q37028772 | Monocytes and macrophages in cancer: development and functions |
| Q36981636 | Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design |
| Q22251045 | Monocytes in atherosclerosis: subsets and functions |
| Q38199685 | Monocytes in health and disease - Minireview |
| Q34959012 | Monocytes in sterile inflammation: recruitment and functional consequences |
| Q28390589 | Monocytes link atherosclerosis and cancer |
| Q89929009 | Monocytes present age-related changes in phospholipid concentration and decreased energy metabolism |
| Q64966156 | Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis. |
| Q33942337 | Monocytes: protagonists of infarct inflammation and repair after myocardial infarction |
| Q38063587 | Mononuclear phagocyte system in kidney disease and repair. |
| Q39250977 | MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4. |
| Q33392688 | MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. |
| Q36043804 | Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation |
| Q43894319 | Myeloid Bmal1 deletion increases monocyte recruitment and worsens atherosclerosis. |
| Q36930766 | Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice |
| Q88985831 | Myeloid cell contributions to cardiovascular health and disease |
| Q34076117 | Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice |
| Q38134246 | Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms |
| Q37399947 | Myeloid cells in atherosclerosis: initiators and decision shapers |
| Q37242355 | Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis |
| Q33968125 | Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice |
| Q35589891 | Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells |
| Q36106602 | Myocardial infarction accelerates atherosclerosis. |
| Q42573987 | NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis |
| Q39417189 | NR4A1-dependent Ly6Clow monocytes contribute to reducing joint inflammation in arthritic mice through Treg cells |
| Q38537648 | Nanoparticle uptake by macrophages in vulnerable plaques for atherosclerosis diagnosis |
| Q100455083 | Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche |
| Q57817810 | Nature and nurture of tissue-specific macrophage phenotypes |
| Q27329117 | Nestin(+) cells direct inflammatory cell migration in atherosclerosis. |
| Q92714930 | Netrin-1 Alters Adipose Tissue Macrophage Fate and Function in Obesity |
| Q37695058 | Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. |
| Q36104871 | Neutrophil secretion products pave the way for inflammatory monocytes |
| Q36984720 | Neutrophil-derived cathelicidin promotes adhesion of classical monocytes |
| Q42433273 | Neutrophils in atherosclerosis: alarmin evidence of a hit and run? |
| Q49531175 | New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases. |
| Q36084389 | Niacin in cardiovascular disease: recent preclinical and clinical developments |
| Q35608570 | Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis |
| Q37476547 | Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling |
| Q30252830 | Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury. |
| Q28080570 | Nonclassical patrolling monocyte function in the vasculature |
| Q37328829 | Noninvasive MRI monitoring of the effect of interventions on endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent |
| Q36079508 | Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders |
| Q38032155 | Novel immune signals and atherosclerosis |
| Q37462172 | Obesity, inflammation, and atherosclerosis |
| Q36200739 | Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions |
| Q37571905 | Omega-3 fatty acids: mechanisms underlying 'protective effects' in atherosclerosis |
| Q37117925 | On-chip phenotypic analysis of inflammatory monocytes in atherogenesis and myocardial infarction |
| Q38763465 | Ontogeny of Tumor-associated Macrophages and Its Implication in Cancer Regulation |
| Q36750759 | Organ-specific features of natural killer cells |
| Q45159606 | Origin of monocytes and macrophages in a committed progenitor |
| Q59806954 | Origin, Differentiation, and Function of Intestinal Macrophages |
| Q40780259 | Orthodontic Force Induces Systemic Inflammatory Monocyte Responses |
| Q41166170 | P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice |
| Q37612342 | P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. |
| Q42101139 | P2Y₆ receptor inhibition perturbs CCL2-evoked signalling in human monocytic and peripheral blood mononuclear cells |
| Q37383780 | PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles |
| Q34632459 | PET/CT imaging of chemokine receptor CCR5 in vascular injury model using targeted nanoparticle |
| Q37790384 | PPARs as therapeutic targets in cardiovascular disease |
| Q47193091 | Patrolling Mechanics of Non-Classical Monocytes in Vascular Inflammation |
| Q37258449 | Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus |
| Q37760424 | Phagocyte partnership during the onset and resolution of inflammation. |
| Q91281532 | Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice |
| Q87203689 | Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice |
| Q30413906 | Phenotypic modulation of macrophages in response to plaque lipids |
| Q40675523 | Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy |
| Q36064574 | Plasmacytoid dendritic cells in atherosclerosis |
| Q37705023 | Platelet-derived chemokines: pathophysiology and therapeutic aspects |
| Q37869351 | Porphyromonas gingivalis-dendritic cell interactions: consequences for coronary artery disease |
| Q38646650 | Primed Polymorphonuclear Leukocytes (PMNLs) from Hemodialysis Patients Enhance Monocyte Transendothelial Migration |
| Q37639995 | Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo |
| Q29619982 | Progress and challenges in translating the biology of atherosclerosis |
| Q37108304 | Progression and disruption of advanced atherosclerotic plaques in murine models |
| Q42004933 | Proliferating macrophages populate established atherosclerotic lesions. |
| Q46617138 | Proliferating macrophages prevail in atherosclerosis |
| Q36862833 | Properties of human blood monocytes. II. Monocytes from healthy adults are highly heterogeneous within and among individuals |
| Q47098170 | Proportions of Proinflammatory Monocytes Are Important Predictors of Mortality Risk in Hemodialysis Patients. |
| Q41894347 | Prostaglandin E 2 Does Not Modulate CCR7 Expression and Functionality after Differentiation of Blood Monocytes into Macrophages |
| Q38991262 | Protective and pathogenic roles of CD8(+) T cells in atherosclerosis |
| Q47989935 | Protective role for CCR5 in murine lupus nephritis |
| Q38854845 | Protein Thiol Redox Signaling in Monocytes and Macrophages |
| Q27319442 | Quantitative analysis of monocyte subpopulations in murine atherosclerotic plaques by multiphoton microscopy |
| Q35218126 | RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling |
| Q36055706 | RIP3-mediated necrotic cell death accelerates systematic inflammation and mortality |
| Q35171696 | Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression |
| Q30300194 | Recent insights into the cellular biology of atherosclerosis |
| Q36449773 | Redefining Myeloid Cell Subsets in Murine Spleen |
| Q30525793 | Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment |
| Q34625670 | Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling |
| Q38560870 | Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back |
| Q24631052 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses |
| Q34372534 | Regulation and consequences of monocytosis |
| Q26852339 | Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis |
| Q27003124 | Regulation of atherogenesis by chemokines and chemokine receptors |
| Q38396097 | Regulation of atherosclerotic plaque inflammation |
| Q28537905 | Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone |
| Q27022667 | Regulation of macrophage and dendritic cell responses by their lineage precursors |
| Q35906690 | Regulation of monocyte functional heterogeneity by miR-146a and Relb |
| Q58148836 | Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization |
| Q37435783 | Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis |
| Q26825806 | Repair after myocardial infarction, between fantasy and reality: the role of chemokines |
| Q90750489 | Replacing Saturated Fat With Unsaturated Fat in Western Diet Reduces Foamy Monocytes and Atherosclerosis in Male Ldlr-/- Mice |
| Q36775202 | Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors |
| Q42789505 | Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques |
| Q48888577 | Rod-Shaped monocytes patrol the brain vasculature and give rise to perivascular macrophages under the influence of proinflammatory cytokines and angiopoietin-2. |
| Q36138041 | Role of Inflammatory Monocytes in Vaccine-Induced Reduction of Helicobacter felis Infection |
| Q64937621 | Role of Macrophages in Cardioprotection. |
| Q50119083 | Role of Monocytes in Heart Failure and Atrial Fibrillation. |
| Q92613057 | Role of microRNA in CB1 antagonist-mediated regulation of adipose tissue macrophage polarization and chemotaxis during diet-induced obesity |
| Q92724115 | Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases |
| Q37493351 | Role of the receptor Mas in macrophage-mediated inflammation in vivo. |
| Q37329566 | Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system |
| Q37704741 | Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease |
| Q27024450 | S100A8 and S100A9 in cardiovascular biology and disease |
| Q34965254 | SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction |
| Q38647432 | STAT1 and IRF8 in Vascular Inflammation and Cardiovascular Disease: Diagnostic and Therapeutic Potential. |
| Q90440175 | STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma |
| Q41932483 | Scavenger Receptor CD36 Directs Nonclassical Monocyte Patrolling Along the Endothelium During Early Atherogenesis |
| Q38577701 | Selective Dependence of Kidney Dendritic Cells on CX3CR1--Implications for Glomerulonephritis Therapy |
| Q33742156 | Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice |
| Q50041053 | Selective recruitment of non-classical monocytes promotes skeletal muscle repair. |
| Q42520959 | Sequential staining improves detection of CCR2 and CX3CR1 on monocytes when simultaneously evaluating CCR5 by multicolor flow cytometry |
| Q36168719 | Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice |
| Q58111873 | Shape Effects of Peptide Amphiphile Micelles for Targeting Monocytes |
| Q45740766 | Silencing CX3CR1 production modulates the interaction between dendritic and endothelial cells |
| Q63560426 | Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression |
| Q50308557 | Skeletal muscle inflammation and insulin resistance in obesity. |
| Q89013999 | Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome |
| Q83396655 | Soluble form of the endothelial adhesion molecule CD146 binds preferentially CD16+ monocytes |
| Q27309244 | Specific depletion of Ly6C(hi) inflammatory monocytes prevents immunopathology in experimental cerebral malaria |
| Q35167972 | Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice |
| Q28741815 | Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages |
| Q34876397 | Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression |
| Q92777021 | Synthesis, 3 H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2 |
| Q36509966 | Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity |
| Q36944695 | T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment |
| Q35894071 | TNF Drives Monocyte Dysfunction with Age and Results in Impaired Anti-pneumococcal Immunity. |
| Q34787176 | TNF-alpha-dependent regulation of acute pancreatitis severity by Ly-6C(hi) monocytes in mice |
| Q37366497 | TREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis. |
| Q91942438 | TREML4 Promotes Inflammatory Programs in Human and Murine Macrophages and Alters Atherosclerosis Lesion Composition in the Apolipoprotein E Deficient Mouse |
| Q37476718 | Targeting Innate Immunity for CV Benefit |
| Q38207732 | Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013). |
| Q49215161 | The Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis. |
| Q52885440 | The Anti-Atherosclerotic Effect of Naringin Is Associated with Reduced Expressions of Cell Adhesion Molecules and Chemokines through NF-κB Pathway. |
| Q36320011 | The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice |
| Q49874464 | The CD300e molecule in mice is an immune-activating receptor. |
| Q91586251 | The Cardiac Microenvironment Instructs Divergent Monocyte Fates and Functions in Myocarditis |
| Q35915712 | The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment |
| Q88399458 | The Ins and Outs of Myeloid Cells in Atherosclerosis |
| Q55207637 | The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties. |
| Q26852646 | The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary Syndromes |
| Q64077128 | The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis |
| Q64084413 | The Roles of Cholesterol and Its Metabolites in Normal and Malignant Hematopoiesis |
| Q33838927 | The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis |
| Q38424659 | The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics |
| Q30439547 | The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury |
| Q38097660 | The complexity of arterial classical monocyte recruitment. |
| Q91386670 | The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation |
| Q38195893 | The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis |
| Q37774869 | The expression and functions of toll-like receptors in atherosclerosis |
| Q37561404 | The fate of monocytes in atherosclerosis |
| Q42840907 | The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes |
| Q37029711 | The fractalkine/CX3CR1 system regulates β cell function and insulin secretion |
| Q29615381 | The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions |
| Q88873056 | The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis |
| Q33817936 | The journey from stem cell to macrophage |
| Q34898069 | The macrophage: the intersection between HIV infection and atherosclerosis. |
| Q37505820 | The monocyte to macrophage transition in the murine sterile wound |
| Q37282249 | The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models |
| Q37741022 | The multiple roles of monocyte subsets in steady state and inflammation |
| Q35685440 | The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques |
| Q59339809 | The physiology of foamy phagocytes in multiple sclerosis |
| Q38236315 | The plasticity of inflammatory monocyte responses to the inflamed central nervous system. |
| Q37939625 | The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. |
| Q37350270 | The role of monocyte phenotype switching in peri-procedural myocardial injury and its involvement in statin therapy |
| Q37766875 | The role of monocytes in atherosclerotic coronary artery disease. |
| Q48175299 | The role of monocytosis and neutrophilia in atherosclerosis |
| Q39211384 | The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases |
| Q37890186 | The spatial and developmental relationships in the macrophage family |
| Q33615950 | The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome |
| Q36990612 | The trafficking of natural killer cells |
| Q35883418 | The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes |
| Q36677300 | The vessel wall and its interactions |
| Q28305924 | Therapeutic inflammatory monocyte modulation using immune-modifying microparticles |
| Q37684793 | Therapeutic targeting of chemokine interactions in atherosclerosis |
| Q50247794 | Thermoneutrality but Not UCP1 Deficiency Suppresses Monocyte Mobilization Into Blood. |
| Q39988367 | Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration |
| Q33660251 | Tip-DC development during parasitic infection is regulated by IL-10 and requires CCL2/CCR2, IFN-gamma and MyD88 signaling |
| Q37611168 | Tracking Monocyte Recruitment and Macrophage Accumulation in Atherosclerotic Plaque Progression Using a Novel hCD68GFP/ApoE-/- Reporter Mouse-Brief Report |
| Q38422828 | Transcriptional programming of human macrophages: on the way to systems immunology |
| Q37700335 | Transcriptional regulation of beta2-microglobulin demonstrated via a novel genomic and proteomic analysis of percutaneously collected peripheral atheroma |
| Q57784167 | Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models |
| Q35241188 | Transcriptome analysis in patients with chronic kidney disease on hemodialysis disclosing a key role for CD16+CX3CR1+ monocytes |
| Q37089723 | Translating molecular discoveries into new therapies for atherosclerosis |
| Q37810915 | Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets |
| Q36497238 | Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. |
| Q36111469 | Triglyceride-Rich Lipoproteins Modulate the Distribution and Extravasation of Ly6C/Gr1(low) Monocytes |
| Q34076041 | Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation |
| Q36883079 | Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. |
| Q34155021 | Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites |
| Q37413679 | Type I interferon modulates monocyte recruitment and maturation in chronic inflammation |
| Q30826655 | Underlying chronic inflammation alters the profile and mechanisms of acute neutrophil recruitment |
| Q92332751 | Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice |
| Q90541775 | Variety matters: Diverse functions of monocyte subtypes in vascular inflammation and atherogenesis |
| Q92314078 | Vascular Macrophages in Atherosclerosis |
| Q41839703 | Vascular calcification: harder than it looks |
| Q30319434 | Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms |
| Q42801094 | Vascular dendritic cells as gatekeepers of lipid accumulation within nascent atherosclerotic plaques |
| Q33813607 | Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers |
| Q52641915 | Visualization of Monocytic Cells in Regressing Atherosclerotic Plaques by Intravital 2-Photon and Positron Emission Tomography-Based Imaging-Brief Report. |
| Q36385767 | Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 diabetic patients |
| Q37170464 | Why targeting HDL should work as a therapeutic tool, but has not. |
| Q37764736 | Xanthogranulomatous pyelonephritis: critical analysis of 30 patients. |
| Q34324735 | miR33 inhibition overcomes deleterious effects of diabetes mellitus on atherosclerosis plaque regression in mice. |
| Q43172902 | wRAPping up early monocyte and neutrophil recruitment in atherogenesis via Annexin A1/FPR2 signaling |
Search more.